Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0B4CD
|
||||
Former ID |
DIB008395
|
||||
Drug Name |
GSK-2018682
|
||||
Synonyms |
PPI-4621; PPI-4667; PPI-4939; PPI-4955; PPI-4667-P; PPI-5955-P; S1P1 receptor agonists (immune disorder), GlaxoSmithKline
|
||||
Indication | Immune disorder [ICD10:D80-D89] | Phase 1 | [523536] | ||
Company |
Praecis Pharmaceuticals Inc
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
c1(c2ccc(OCc3ccc(c4ccccc4)cc3)c(c2)C(F)(F)F)[nH]c(nc1)[<br />C@](CO)(N)C
|
||||
Target and Pathway | |||||
Target(s) | Sphingosine 1-phosphate receptor 1 | Target Info | Agonist | [532456] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.